FDA NDC Directory · JSON-LD · Markdown

Lisdexamfetamine dimesylate

NDC 0781-2476 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA202836
Dosage form / routeCAPSULE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (20 mg/1)
Marketing started20250916
Package count1

External sources

Source: openFDA. Public-domain (CC0).